Pregnancy and neonatal outcomes in COVID-19: study protocol for a global registry of women with suspected or confirmed SARS-CoV-2 infection in pregnancy and their neonates, understanding natural history to guide treatment and prevention.
Pregnancy and neonatal outcomes in COVID-19: study protocol for a global registry of women with suspected or confirmed SARS-CoV-2 infection in pregnancy and their neonates, understanding natural history to guide treatment and prevention.
复制标题
DOI:
10.1136/bmjopen-2020-041247
复制
发表时间:
2021-01-29
期刊:
影响因子:
2.9
通讯作者:
Lees C
中科院分区:
文献类型:
--
作者:
Banerjee J;Mullins E;Townson J;Playle R;Shaw C;Kirby N;Munnery K;Bourne T;Teoh TG;Dhanjal M;Poon L;Wright A;Lees C
Previous novel COVID-19 pandemics, SARS and middle east respiratory syndrome observed an association of infection in pregnancy with preterm delivery, stillbirth and increased maternal mortality. COVID-19, caused by SARS-CoV-2 infection, is the largest pandemic in living memory. Rapid accrual of robust case data on women in pregnancy and their babies affected by suspected COVID-19 or confirmed SARS-CoV-2 infection will inform clinical management and preventative strategies in the current pandemic and future outbreaks. The pregnancy and neonatal outcomes in COVID-19 (PAN-COVID) registry are an observational study collecting focused data on outcomes of pregnant mothers who have had suspected COVID-19 in pregnancy or confirmed SARS-CoV-2 infection and their neonates via a web-portal. Among the women recruited to the PAN-COVID registry, the study will evaluate the incidence of: (1) miscarriage and pregnancy loss, (2) fetal growth restriction and stillbirth, (3) preterm delivery, (4) vertical transmission (suspected or confirmed) and early onset neonatal SARS-CoV-2 infection. Data will be centre based and collected on individual women and their babies. Verbal consent will be obtained, to reduce face-to-face contact in the pandemic while allowing identifiable data collection for linkage. Statistical analysis of the data will be carried out on a pseudonymised data set by the study statistician. Regular reports will be distributed to collaborators on the study research questions. This study has received research ethics approval in the UK. For international centres, evidence of appropriate local approval will be required to participate, prior to entry of data to the database. The reports will be published regularly. The outputs of the study will be regularly disseminated to participants and collaborators on the study website (https://pan-covid.org) and social media channels as well as dissemination to scientific meetings and journals. ISRCTN68026880.
登录
查看更多内容
影响因子:
105.7
作者:
Knight, Marian;Bunch, Kathryn;Kurinczuk, Jennifer J.
通讯作者:
Kurinczuk, Jennifer J.
影响因子:
9.8
作者:
Wong SF;Chow KM;Leung TN;Ng WF;Ng TK;Shek CC;Ng PC;Lam PW;Ho LC;To WW;Lai ST;Yan WW;Tan PY
通讯作者:
Tan PY
影响因子:
64.8
作者:
Olival KJ;Hosseini PR;Zambrana-Torrelio C;Ross N;Bogich TL;Daszak P
通讯作者:
Daszak P
影响因子:
2.5
作者:
Gobat, Nina H.;Gal, Micaela;Nichol, Alistair
通讯作者:
Nichol, Alistair
DOI:
10.1136/bmj.d3214
发表时间:
2011-06-14
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Pierce M;Kurinczuk JJ;Spark P;Brocklehurst P;Knight M;UKOSS
通讯作者:
UKOSS